Suraksha Pharma Private Limited, a active private limited company, was established on 08 May 1998 in Tirumalagiri, Telangana, India. Engaging in personal care & skincare products within the manufacturing sector, it holds CIN: U24230TG1998PTC029377. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹10.00 Cr and a paid-up capital of ₹6.05 Cr.
It upholds a compliant status. Employing 108 professional, Its leadership includes Nageswararao Gupta Manepalli (Managing Director), Raghva Tayaru Aswani Manepalli (Whole-Time Director), Padmaja Rani Manepalli (Whole-Time Director). Past directors included Raghva Tayaru Aswani Manepalli, Someswara Rao Manepalli, Naga Venkata Kanaka Manepalli Satyanarayana Murthy. It holds ₹19.18 Cr open charges and ₹3.92 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Hig 101, H.No.15-31-1, Phase-5, D Mart Lane, Kphb Colony, Tirumalagiri, Telangana, 500072.
U24230TG1998PTC029377
029377
08 May 1998
₹10.00 Cr
₹6.05 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Suraksha Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nageswararao Gupta Manepalli | Managing Director | 13 May 1998 | Current |
| Raghva Tayaru Aswani Manepalli | Whole-Time Director | 21 Feb 2019 | Current |
| Padmaja Rani Manepalli | Whole-Time Director | 01 Apr 2016 | Current |
| Someswara Rao Manepalli | Whole-Time Director | 29 Sep 2006 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Mar 2019 | Past |
| Pramod Abcsdd | Director | 15 Nov 2018 | Past |
| Pramod Abcsdd | Director | 26 Mar 2012 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Suraksha Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 15.98% decrease. The company also saw a slight improvement in profitability, with a 1.96% increase in profit. The company's net worth moved up by a moderate rise of 8.79%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Suraksha Pharma had a promoter holding of 100.00%. The company had 2 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹191,820,739.00
₹39,160,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 May 2025 | Others | ₹2.84 Cr | Open |
| 05 Dec 2024 | Others | ₹3.38 Cr | Open |
| 11 Jul 2012 | Others | ₹12.97 Cr | Open |
| 31 Jan 2022 | Others | ₹2.00 Cr | Satisfied |
| 12 Mar 2007 | Punjab National Bank | ₹1.92 Cr | Satisfied |
Explore comprehensive loan charge details -
Suraksha Pharma has a workforce of 108 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Suraksha Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Suraksha Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge registered on 31 Jan 2022 via Charge ID 100544902 with Others was fully satisfied on 02 Jun 2025. was completed.
The activity A charge with Others amounted to Rs. 2.84 Cr with Charge ID 101105281 was registered on 27 May 2025. was completed.
A charge with Others amounted to Rs. 3.38 Cr with Charge ID 101015312 was registered on 05 Dec 2024. was recorded as a recent event.
Progress on Suraksha Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Suraksha Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was recorded as a recent event.
The activity A charge with Others of Rs. 12.97 Cr registered on 11 Jul 2012 with Charge ID 10371023 was modified on 20 Dec 2022. was completed.
The CIN of Suraksha Pharma Private Limited is U24230TG1998PTC029377.
Suraksha Pharma Private Limited is headquartered at Hig 101, H.No.15-31-1, Phase-5, D Mart Lane, Kphb Colony, Tirumalagiri, Telangana, 500072.
Suraksha Pharma Private Limited was incorporated on 08 May 1998.
The current directors of Suraksha Pharma Private Limited are
The primary industry of Suraksha Pharma Private Limited is Manufacturing.
Suraksha Pharma Private Limited is unlisted.
The authorized capital of Suraksha Pharma Private Limited is ₹10.00 Cr, and the paid-up capital is ₹6.05 Cr.
The compliance status of Suraksha Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX